Meihua International Medical Technologies Co., Ltd. (MHUA)
USD 0.32
(9.03%)
USD 0.32
(9.03%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 171.91 Million USD | 5.1% |
| 2022 | 163.57 Million USD | 19.52% |
| 2021 | 136.85 Million USD | 29.05% |
| 2020 | 106.04 Million USD | 44.87% |
| 2019 | 73.2 Million USD | 17.28% |
| 2018 | 62.41 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 179.16 Million USD | 0.0% |
| 2024 Q1 | 179.16 Million USD | 4.22% |
| 2023 Q4 | 171.91 Million USD | 0.0% |
| 2023 Q1 | 162.61 Million USD | -0.59% |
| 2023 FY | 171.91 Million USD | 5.1% |
| 2023 Q3 | 171.91 Million USD | 5.72% |
| 2023 Q2 | 162.61 Million USD | 0.0% |
| 2022 Q4 | 163.57 Million USD | 0.0% |
| 2022 Q3 | 163.57 Million USD | -1.01% |
| 2022 FY | 163.57 Million USD | 19.52% |
| 2022 Q2 | 165.25 Million USD | 0.0% |
| 2022 Q1 | 165.25 Million USD | 20.75% |
| 2021 Q1 | 118.55 Million USD | 11.79% |
| 2021 FY | 136.85 Million USD | 29.05% |
| 2021 Q4 | 136.85 Million USD | 0.0% |
| 2021 Q2 | 118.55 Million USD | 0.0% |
| 2021 Q3 | 136.85 Million USD | 15.44% |
| 2020 Q3 | 106.04 Million USD | 17.11% |
| 2020 Q4 | 106.04 Million USD | 0.0% |
| 2020 Q2 | 90.55 Million USD | 0.0% |
| 2020 Q1 | 90.55 Million USD | 23.7% |
| 2020 FY | 106.04 Million USD | 44.87% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 73.2 Million USD | 17.28% |
| 2019 Q4 | 73.2 Million USD | 0.0% |
| 2019 Q3 | 73.2 Million USD | 0.0% |
| 2018 FY | 62.41 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 4.687% |
| AngioDynamics, Inc. | 317.67 Million USD | 45.883% |
| AtriCure, Inc. | 613.93 Million USD | 71.998% |
| Avinger, Inc. | 13.77 Million USD | -1148.477% |
| Azenta, Inc. | 2.88 Billion USD | 94.043% |
| BioLife Solutions, Inc. | 412.71 Million USD | 58.345% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 98.525% |
| Daxor Corporation | 34.86 Million USD | -393.03% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -494.492% |
| Femasys Inc. | 27.75 Million USD | -519.384% |
| GlucoTrack, Inc. | 4.9 Million USD | -3404.899% |
| Harvard Bioscience, Inc. | 137.36 Million USD | -25.151% |
| Hologic, Inc. | 9.15 Billion USD | 98.122% |
| ICU Medical, Inc. | 4.37 Billion USD | 96.074% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 98.887% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -504.039% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 50.425% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -2664.461% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -2664.461% |
| Masimo Corporation | 3.04 Billion USD | 94.348% |
| Microbot Medical Inc. | 8.32 Million USD | -1964.552% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 92.607% |
| Nephros, Inc. | 11.86 Million USD | -1349.416% |
| NovoCure Limited | 1.14 Billion USD | 85.0% |
| NEXGEL, Inc. | 9.95 Million USD | -1626.924% |
| NEXGEL, Inc. | 9.95 Million USD | -1626.924% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 35.24% |
| OraSure Technologies, Inc. | 482.84 Million USD | 64.395% |
| Pro-Dex, Inc. | 54.21 Million USD | -217.128% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -182.737% |
| Predictive Oncology Inc. | 14.41 Million USD | -1092.428% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -916.494% |
| QuidelOrtho Corporation | 8.56 Billion USD | 97.992% |
| Repligen Corporation | 2.82 Billion USD | 93.913% |
| Sanara MedTech Inc. | 73.87 Million USD | -132.723% |
| STAAR Surgical Company | 488.69 Million USD | 64.821% |
| Sharps Technology, Inc. | 11.78 Million USD | -1358.235% |
| Utah Medical Products, Inc. | 135.45 Million USD | -26.914% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 97.667% |
| Jin Medical International Ltd. | 32.9 Million USD | -422.484% |